-
公开(公告)号:US12103921B2
公开(公告)日:2024-10-01
申请号:US18322844
申请日:2023-05-24
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Shawn Cabral , Agustin Casimiro Garcia , Ming Zhu Chen , Chulho Choi , Robert Lee Dow , Olugbeminiyi Omezia Fadeyi , David Hepworth , Jayasankar Jasti , Lyn Howard Jones , Arjun Venkat Narayanan , Mihir Dineshkumar Parikh , David Walter Piotrowski , Lee Richard Roberts , Ralph Pelton Robinson, Jr. , Hatice Gizem Yayla
IPC: C07D401/14 , A61K45/06 , A61P7/06 , C07D471/04
CPC classification number: C07D401/14 , A61P7/06 , C07D471/04 , A61K45/06
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
More particularly the invention relates to HbS modulators of formula (I)
or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description.
HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).-
公开(公告)号:US10906888B2
公开(公告)日:2021-02-02
申请号:US16316688
申请日:2017-07-07
Applicant: Pfizer Inc.
Inventor: Agustin Casimiro-Garcia , Joseph Walter Strohbach , David Hepworth , Frank Eldridge Lovering , Chulho Choi , Christophe Philippe Allais , Stephen Wayne Wright
IPC: C07D401/14 , C07D403/14 , C07D413/14 , C07D471/08 , C07D487/04 , C07D487/10 , C07D491/107 , C07D498/10 , C07D498/18
Abstract: Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
公开(公告)号:US20200172512A1
公开(公告)日:2020-06-04
申请号:US16695709
申请日:2019-11-26
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Arjun Venkat Narayanan , Agustin Casimiro-Garcia , Chulho Choi , David Hepworth , David Walter Piotrowski , Hatice Gizem Yayla , Jayasankar Jasti , Lee Richard Roberts , Lyn Howard Jones , Mihir Dineshkumar Parikh , Ming Zhu Chen , Olugbeminiyi Omezia Fadeyi , Ralph Pelton Robinson, JR. , Robert Lee Dow , Shawn Cabral
IPC: C07D401/14 , C07D471/04 , A61P7/06
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.More particularly the invention relates to HbS modulators of formula (I) or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description.HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).
-
公开(公告)号:US20230382892A1
公开(公告)日:2023-11-30
申请号:US18322844
申请日:2023-05-24
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Shawn Cabral , Agustin Casimiro Garcia , Ming Zhu Chen , Chulho Choi , Robert Lee Dow , Olugbeminiyi Omezia Fadeyi , David Hepworth , Jayasankar Jasti , Lyn Howard Jones , Arjun Venkat Narayanan , Mihir Dineshkumar Parikh , David Walter Piotrowski , Lee Richard Roberts , Ralph Pelton Robinson, Jr. , Hatice Gizem Yayla
IPC: C07D401/14 , A61P7/06 , C07D471/04
CPC classification number: C07D401/14 , A61P7/06 , C07D471/04 , A61K45/06
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
More particularly the invention relates to HbS modulators of formula (I)
or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description.
HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).-
公开(公告)号:US11014908B2
公开(公告)日:2021-05-25
申请号:US16695709
申请日:2019-11-26
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Arjun Venkat Narayanan , Agustin Casimiro-Garcia , Chulho Choi , David Hepworth , David Walter Piotrowski , Hatice Gizem Yayla , Jayasankar Jasti , Lee Richard Roberts , Lyn Howard Jones , Mihir Dineshkumar Parikh , Ming Zhu Chen , Olugbeminiyi Omezia Fadeyi , Ralph Pelton Robinson, Jr. , Robert Lee Dow , Shawn Cabral
IPC: C07D401/14 , A61P7/06 , C07D471/04 , A61K45/06
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
More particularly the invention relates to HbS modulators of formula (I) or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description. HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).-
公开(公告)号:US20240109915A1
公开(公告)日:2024-04-04
申请号:US18359709
申请日:2023-07-26
Applicant: Pfizer Inc.
Inventor: Scott William Bagley , Andrea Nicole Bootsma , Chulho Choi , Robert Lee Dow , David James Edmonds , Carmen Noemi Garcia-Irizarry , Brian Stephen Gerstenberger , Gajendra Ingle , Jessica Gloria Katherine O'Brien , Mihir Dineshkumar Parikh , Gwenaella Christine Rescourio , Daniel Copley Schmitt
IPC: C07D513/10
CPC classification number: C07D513/10
Abstract: A compound having the structures:
or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate of said compound or pharmaceutically acceptable salt, wherein; R selected from the group consisting of H, C1-C6 alkyl, C1-C6 alkoxy and —(CH2)m—W, where W is C3-C8 cycloalkyl, bicycloalkyl, bridged bicycloalkyl, phenyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said alkyl, cycloalkyl, alkoxy, heterocyclic, phenyl, naphthyl or heteroaryl may be unsubstituted or substituted by phenyl, halo, cyano, deuterium, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, —SO2—R′, —CONR′R″, NR′COR″, —NR′CONR′R″, —NR′CO2R″, —(CH2)n—SO2—R′, —NHSO2—R′, —NR″SO2—R′, —SO2NR′R″, NR′R″ or SR′ where R′ and R″ are independently H, C1-C6 alkyl or C3-C8 cycloalkyl; R1 selected from the group consisting of phenyl, naphthyl, 5- or 6-membered heteroaryl or heterocyclic containing one, two, three or four heteroatoms selected from the group consisting of N, S and O atoms; and, a 9- or 10-membered bicyclic aryl, heteroaryl or heterocyclic containing one, two or three heteroatoms selected from the group consisting of N, S and O atoms; wherein each of said phenyl, naphthyl, aryl, heterocyclic, or heteroaryl may be unsubstituted or substituted by halo, cyano, deuterium, hydroxy, C1-C6 alkyl, C1-C6 alkoxy, phenyl, —SO2—R′, —CONR′R″, NR′COR″, —NR′CONR′R″, —NR′CO2R″, —(CH2)n—SO2—R′, —NHSO2—R′, —NR″SO2—R, —SO2NR′R″, —P(O)R′R″,
or NR′R″′ or SR′ where R′ and R″ are independently H, C1-C6 alkyl or C3-C8 cycloalkyl; and, m and n are independently 0, 1, 2 or 3. The invention also relates to pharmaceutically acceptable salts of these compounds and to pharmaceutically acceptable solvates thereof; to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly acne.-
公开(公告)号:US11702405B2
公开(公告)日:2023-07-18
申请号:US17227819
申请日:2021-04-12
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Shawn Cabral , Agustin Casimiro-Garcia , Ming Zhu Chen , Chulho Choi , Robert Lee Dow , Olugbeminiyi Omezia Fadeyi , David Hepworth , Jayasankar Jasti , Lyn Howard Jones , Arjun Venkat Narayanan , Mihir Dineshkumar Parikh , David Walter Piotrowski , Lee Richard Roberts , Ralph Pelton Robinson, Jr. , Hatice Gizem Yayla
IPC: C07D401/14 , A61P7/06 , C07D471/04 , A61K45/06
CPC classification number: C07D401/14 , A61P7/06 , C07D471/04 , A61K45/06
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
More particularly the invention relates to HbS modulators of formula (I)
or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description.
HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).-
公开(公告)号:US20220348555A1
公开(公告)日:2022-11-03
申请号:US17227819
申请日:2021-04-12
Applicant: Pfizer Inc.
Inventor: Ariamala Gopalsamy , Shawn Cabral , Agustin Casimiro-Garcia , Ming Zhu Chen , Chulho Choi , Robert Lee Dow , Olugbeminiyi Omezia Fadeyi , David Hepworth , Jayasankar Jasti , Lyn Howard Jones , Arjun Venkat Narayanan , Mihir Dineshkumar Parikh , David Walter Piotrowski , Lee Richard Roberts , Ralph Pelton Robinson, Jr. , Hatice Gizem Yayla
IPC: C07D401/14 , A61P7/06 , C07D471/04
Abstract: The invention relates to pyrazole derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.
More particularly the invention relates to HbS modulators of formula (I) or tautomers thereof, or pharmaceutically acceptable salts of said modulators or tautomers thereof, wherein X, Y, R2 and R3 are as defined in the description.
HbS modulators are potentially useful in the treatment of a wide range of disorders, including sickle cell disease (SCD).-
公开(公告)号:US20190315715A1
公开(公告)日:2019-10-17
申请号:US16316688
申请日:2017-07-07
Applicant: Pfizer Inc.
Inventor: Agustin Casimiro-Garcia , Joseph Walter Strohbach , David Hepworth , Frank Eldridge Lovering , Chulho Choi , Christophe Philippe Allais , Stephen Wayne Wright
IPC: C07D401/14 , C07D403/14 , C07D413/14 , C07D471/08 , C07D487/04 , C07D487/10 , C07D491/107 , C07D498/10 , C07D498/18
Abstract: Compounds, pharmaceutically acceptable salts thereof, are disclosed wherein the compounds have the structure of (I) as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
-
-
-
-
-
-
-
-